Literature DB >> 17165789

Conformational preference of polyglycine in solution to elongated structure.

Satoshi Ohnishi1, Hironari Kamikubo, Masayoshi Onitsuka, Mikio Kataoka, David Shortle.   

Abstract

Do polypeptide chains ever behave like a random coil? In this report we demonstrate that glycine, the residue with the fewest backbone restrictions, exhibits a strong preference for an extended conformation in solution when polymerized in short segments of polyglycine. A model peptide system comprised of two unique tripeptide units, between which 1 to 18 glycine residues are inserted, is characterized by NMR and by small-angle X-ray scattering (SAXS). The residual dipolar coupling (RDC) values of the two tripeptide units are insensitive to changes in number of intervening glycines, suggesting that extension of the linker does not alter the average angular relationship between the tripeptides. Polyglycine segments longer than nine residues form insoluble aggregates. SAXS measurements using synchrotron radiation provide direct evidence that polyglycine peptides adopt elongated conformations. In particular, the construct with a linker with six glycines showed a scattering profile indicative of a monomeric state with a radius of gyration and the maximum dimension of 9.1 A and approximately 34 A, respectively. The ensemble averaged global structure of this 12-mer peptide can best be approximated by a cylinder with a radius of 4 A and a length of approximately 33 A, making it intermediate in extension between a beta strand and an alpha helix.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17165789     DOI: 10.1021/ja066008b

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  27 in total

1.  Sequence-dependent stability test of a left-handed β-helix motif.

Authors:  Natha R Hayre; Rajiv R P Singh; Daniel L Cox
Journal:  Biophys J       Date:  2012-03-20       Impact factor: 4.033

2.  Mutational analysis of the transmembrane helix 2-HAMP domain connection in the Escherichia coli aspartate chemoreceptor tar.

Authors:  Gus A Wright; Rachel L Crowder; Roger R Draheim; Michael D Manson
Journal:  J Bacteriol       Date:  2010-09-24       Impact factor: 3.490

3.  Theoretical framework for NMR residual dipolar couplings in unfolded proteins.

Authors:  O I Obolensky; Kai Schlepckow; Harald Schwalbe; A V Solov'yov
Journal:  J Biomol NMR       Date:  2007-07-07       Impact factor: 2.835

Review 4.  Experimental approaches for solution X-ray scattering and fiber diffraction.

Authors:  H Tsuruta; T C Irving
Journal:  Curr Opin Struct Biol       Date:  2008-09-29       Impact factor: 6.809

Review 5.  Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.

Authors:  Teresa Botta-Orfila; Gian Gaetano Tartaglia; Aubin Michalon
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

6.  Perplexing cooperative folding and stability of a low-sequence complexity, polyproline 2 protein lacking a hydrophobic core.

Authors:  Zachary P Gates; Michael C Baxa; Wookyung Yu; Joshua A Riback; Hui Li; Benoît Roux; Stephen B H Kent; Tobin R Sosnick
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

Review 7.  Biomolecular engineering for nanobio/bionanotechnology.

Authors:  Teruyuki Nagamune
Journal:  Nano Converg       Date:  2017-04-24

8.  Entropic stabilization of proteins by TMAO.

Authors:  Samuel S Cho; Govardhan Reddy; John E Straub; D Thirumalai
Journal:  J Phys Chem B       Date:  2011-10-26       Impact factor: 2.991

9.  Probing the disordered domain of the nuclear pore complex through coarse-grained molecular dynamics simulations.

Authors:  Ali Ghavami; Liesbeth M Veenhoff; Erik van der Giessen; Patrick R Onck
Journal:  Biophys J       Date:  2014-09-16       Impact factor: 4.033

10.  Phase Separation of Toxic Dipeptide Repeat Proteins Related to C9orf72 ALS/FTD.

Authors:  Hamidreza Jafarinia; Erik van der Giessen; Patrick R Onck
Journal:  Biophys J       Date:  2020-07-16       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.